Another Patient Cleared of HIV with Stem Cell Transplant
A 53-year-old man in Germany, referred to as the ‘Düsseldorf patient’, has become the fifth person to be declared cleared of HIV after a bone marrow transplant that replaced his cells with HIV-resistant stem cells from a donor. The procedure was first used on Timothy Ray Brown, the ‘Berlin patient,’ in 2007, and later on […]
ExCellThera announces completion of Phase 2 clinical trials for UM171-expanded cell therapy in high-risk blood cancers
MONTREAL, Nov. 15, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today the completion of patient enrollment in its initial Phase 2 studies for high-risk leukemias and myelodysplastic syndromes (MDS). ECT-001 Cell Therapy, ExCellThera’s most advanced investigational drug, combines the proprietary molecule UM171 and an […]
Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World Cord Blood Day 2022
TUCSON, Ariz., Sept. 14, 2022 /PRNewswire/ — We are pleased to announce World Cord Blood Day 2022 (WCBD 2022) will take place on November 15th, featuring a free online medical conference and educational events worldwide. This year’s official online conference will highlight innovations in cancer-fighting stem cell transplants using cord blood, as well as ground-breaking […]
Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
NEW YORK and LONDON, July 07, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, today announced that a patient has completed the course of investigational nomacopan treatment in the open-label, multi-center Phase III Part A clinical trial in pediatric hematopoietic stem cell transplant-related […]
Jasper Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium
REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will participate at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022. Ronald Martell, Chief Executive Officer, Jeet Mahal, Chief Operating & […]
Autologous Stem Cell Transplants for Blood Cancer Patients
This animated video explains the purpose and procedure of Autologous Stem Cell Transplants for blood cancer patients. Video Transcript: Autologous stem cell transplants are a type of treatment for certain blood cancers that require very high doses of chemotherapy or radiation to treat their disease. Chemotherapy or chemo may kill cancer cells, but it also […]
Third Person with HIV Cured by Stem Cell Transplant
A breakthrough stem cell treatment has likely cured a third person of HIV. The stem cell transplant combined adult stem cells taken from a relative’s blood along with umbilical cord blood that was genetically matched from a cord blood bank. The cord blood contained genetic mutation resistant to HIV which caused the patient’s immune system […]